The Global Organ Preservation Solution Market Size is projected to grow at a CAGR of 9.7% during the forecast period from 2026 to 2034 | DelveInsight

DelveInsight's Organ Preservation Solution Market Insights Report 2034 provides the current and forecast market analysis, individual leading Organ Preservation Solution Companies market shares, challenges, Organ Preservation Solution Market Drivers, barriers, trends, and key market Surgical Sutures companies in the market.

To read more about the latest highlights related to the Organ Preservation Solution Market @ https://www.delveinsight.com/sample-request/organ-preservation-solution-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=yash

Key Takeaways from the Organ Preservation Solution Market Report
• In May 2026, Bridge to Life Ltd. presented new data at the ILTS 2026 meeting showing that its VitaSmart hypothermic oxygenated perfusion system expands utilization of steatotic and older donor livers while preserving mitochondrial function for real-time viability assessment. Strategic significance: Reinforces Bridge to Life's leadership in perfusion-based preservation and strengthens the clinical case for broader hypothermic oxygenated perfusion adoption.
• The Organ Preservation Solution Market is estimated at USD 340 million in 2025 and is projected to reach USD 785 million by 2034. Growth is anchored by the rising number of organ transplant procedures and growing burden of end-stage organ failure, increasing organ donation rates, and expansion of transplant centers and organ procurement organizations, and increasing government initiatives supporting organ donation.
• The Global Organ Preservation Solution Market is growing at a CAGR of 9.7% during the forecast period from 2026 to 2034.
• The leading Organ Preservation Solution Companies include Bridge to Life Ltd., XVIVO Perfusion AB, Institut Georges Lopez (IGL), Dr. Franz Köhler Chemie GmbH, Organ Recovery Systems, TransMedics, Inc., OrganOx Limited, Preservation Solutions, Inc., Essential Pharmaceuticals LLC, Paragonix Technologies, Carnamedica Sp. z o.o., S.A.L.F. S.p.A., Waters Medical Systems LLC, Transplant Biomedicals S.L., Vivalyx GmbH and others.
• The principal drivers are rising global organ transplant volumes, with the United States recording 48,149 transplants in 2024; the expanding donor pool, including growing use of donation-after-circulatory-death and marginal donor organs; the clinical shift from static cold storage toward hypothermic oxygenated and normothermic machine perfusion; the rising global burden of chronic kidney, liver, and heart disease; and accelerating regulatory clearances for machine perfusion solutions and platforms.

To know more about why North America is leading the market growth in the Organ Preservation Solution Market, Get a snapshot @ https://www.delveinsight.com/sample-request/organ-preservation-solution-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=yash

Organ Preservation Solution Overview
Organ preservation solutions are specialized sterile solutions designed to protect and maintain the viability of donor organs between procurement and transplantation. These solutions help minimize cellular damage caused by ischemia, reduce metabolic activity, and preserve organ function during storage and transportation. They play a vital role in improving transplant outcomes by extending the acceptable preservation time and maintaining the structural and functional integrity of organs such as the kidneys, liver, heart, lungs, and pancreas.

Organ Preservation Solution Market Key Growth Drivers
• The rising number of organ transplantation procedures worldwide is significantly driving demand for Organ Preservation Solutions, supported by increasing kidney, liver, heart, lung, and pancreas transplant volumes and expanding transplant programs across developed and emerging economies.
• The growing shortage of donor organs is accelerating the adoption of advanced preservation solutions that extend organ viability, reduce ischemia-reperfusion injury, and improve graft utilization, thereby increasing the success rate of transplantation.
• The increasing prevalence of end-stage organ failure and chronic diseases, including Chronic Kidney Disease, Liver Cirrhosis, Heart Failure, and chronic lung diseases, is expanding the global transplant candidate pool and fueling demand for effective organ preservation technologies.
• Continuous advancements in hypothermic machine perfusion (HMP), normothermic machine perfusion (NMP), and ex vivo organ perfusion systems are boosting the use of specialized preservation solutions optimized for dynamic perfusion, improving organ quality and post-transplant outcomes.
• Rising investments by governments, transplant organizations, and healthcare institutions in organ donation awareness programs, transplant infrastructure, and organ procurement networks are increasing the number of donor organs recovered and preserved, supporting market growth.
• Regulatory approvals, clinical research, and commercialization of next-generation preservation solutions with enhanced antioxidant, anti-inflammatory, and cytoprotective properties are improving graft survival and expanding their adoption across multiple organ types.
• The convergence of increasing transplantation volumes, rising burden of end-stage organ diseases, technological advancements in organ preservation, expanding transplant infrastructure, and continued innovation in preservation solutions is expected to sustain strong growth in the global Organ Preservation Solution market through the forecast period.

Get a sneak peek at the Tele Organ Preservation Solution Market Dynamics @ https://www.delveinsight.com/sample-request/organ-preservation-solution-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=yash

Organ Preservation Solution Market Segment Analysis
The Organ Preservation Solution Market Product Type (Organ Preservation Solutions [UW Solution, HTK Solution, Celsior Solution, IGL-1 Solution, Perfadex, EuroCollins/Collins Solution, and Others] and Perfusion Solutions/Machine Perfusion [Hypothermic Machine Perfusion (HMP) Solutions, Hypothermic Oxygenated Perfusion (HOPE/D-HOPE) Solutions, Normothermic Machine Perfusion (NMP) Solutions, Subnormothermic/Controlled Oxygenated Rewarming Solutions, and Other Proprietary Perfusion Solutions]), Application (Procurement, Preservation, Transportation, Pre-Implantation, and Post-Implantation), Organ Type (Kidney, Liver, Heart, Pancreas, and Others), and Geography (North America, Europe, Asia-Pacific, Rest of World).

Organ Preservation Solution Market Competitive Landscape
The Organ Preservation Solution market is classified as Fragmented. A semi-consolidated group of established solution manufacturers, including Bridge to Life, XVIVO Perfusion, Dr. Franz Köhler Chemie, and Institut Georges Lopez, anchors the leading tier through proprietary formulations, regulatory approvals, and global distribution networks, while numerous small- to mid-size regional producers, including Preservation Solutions, Waters Medical Systems, Carnamedica, and Global Transplant Solutions, compete through localized distribution, pricing, and niche organ-specific formulations, sustaining a broad and competitive supplier base.

Which MedTech key players in the Organ Preservation Solution Market are set to emerge as the trendsetter explore @ https://www.delveinsight.com/sample-request/organ-preservation-solution-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=yash

Organ Preservation Solution Companies
Bridge to Life Ltd., XVIVO Perfusion AB, Institut Georges Lopez (IGL), Dr. Franz Köhler Chemie GmbH, Organ Recovery Systems, TransMedics, Inc., OrganOx Limited, Preservation Solutions, Inc., Essential Pharmaceuticals LLC, Paragonix Technologies, Carnamedica Sp. z o.o., S.A.L.F. S.p.A., Waters Medical Systems LLC, Transplant Biomedicals S.L., Vivalyx GmbH and others.

Organ Preservation Solution Market Restraints
Despite strong momentum, the Organ Preservation Solution market faces material constraints. Machine perfusion solutions and the platforms that deliver them carry substantially higher costs than conventional static cold storage, which can limit adoption among smaller transplant centers and in cost-constrained healthcare systems. The short viable window of donor organs imposes severe time and logistics constraints, requiring precise cold-chain handling and rapid transportation that can be difficult to guarantee across long distances or in regions with underdeveloped transplant infrastructure. Regulatory approval pathways for new preservation and perfusion chemistries can be lengthy, as illustrated by delays in CE certification for novel heart preservation solutions pending additional scientific review, which slows the pace of new product introduction. Reimbursement for machine perfusion remains uneven across geographies, and a shortage of personnel trained in perfusion techniques constrains scale-up at transplant centers seeking to adopt newer technologies.

Interested in knowing the Organ Preservation Solution Market by 2034? Click to get a snapshot of the Organ Preservation Solution Market Trends- https://www.delveinsight.com/sample-request/organ-preservation-solution-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=yash

Scope of the Organ Preservation Solution Market Report
• Coverage- Global
• Forecast Period- 2025-2034
• Organ Preservation Solution Companies- Bridge to Life Ltd., XVIVO Perfusion AB, Institut Georges Lopez (IGL), Dr. Franz Köhler Chemie GmbH, Organ Recovery Systems, TransMedics, Inc., OrganOx Limited, Preservation Solutions, Inc., Essential Pharmaceuticals LLC, Paragonix Technologies, Carnamedica Sp. z o.o., S.A.L.F. S.p.A., Waters Medical Systems LLC, Transplant Biomedicals S.L., Vivalyx GmbH and others.
• Organ Preservation Solution Market Restraints and Regulatory Analysis
• Organ Preservation Solution Porter Five Forces Analysis
• Organ Preservation Solution Market Assessment

Explore more information of the Organ Preservation Solution Market Insights @ https://www.delveinsight.com/sample-request/organ-preservation-solution-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=yash

Table of Contents
1. Organ Preservation Solution Market Report Introduction
2. Organ Preservation Solution Market Executive Summary
3. Organ Preservation Solution Competitive Landscape
4. Organ Preservation Solution Regulatory Analysis
5. Organ Preservation Solution Market Key Factors Analysis
6. Organ Preservation Solution Market Porter's Five Forces Analysis
7. Organ Preservation Solution Market Assessment
8. Organ Preservation Solution Market Company and Product Profiles
9. KOL Views
10. Project Approach
11. About DelveInsight
12. Disclaimer & Contact Us

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: info@delveinsight.com
Phone: 09650213330
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

This release was published on openPR.